Stapled peptide-based membrane fusion inhibitors of hepatitis C virus

被引：61

作者：

Cui, Hong-Kui ^{[1
]}

Qing, Jie ^{[1
]}

Guo, Ye ^{[1
]}

Wang, Yu-Jia ^{[1
]}

Cui, Li-Jia ^{[2
,3
]}

He, Tian-Hua ^{[2
,3
]}

Zhang, Linqi ^{[2
,3
]}

Liu, Lei ^{[1
]}

机构：

[1] Tsinghua Univ, Dept Chem, Tsinghua Peking Ctr Life Sci,Minist Educ, Key Lab Bioorgan Phosphorus Chem & Chem Biol, Beijing 100084, Peoples R China

[2] Tsinghua Univ, Sch Med, Comprehens AIDS Res Ctr, Beijing 100084, Peoples R China

[3] Tsinghua Univ, Sch Med, Res Ctr Publ Hlth, Beijing 100084, Peoples R China

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2013年 / 21卷 / 12期

基金：

中国国家自然科学基金;

关键词：

Hepatitis C virus; Stapled peptide; Protein-protein interaction; CELL-CULTURE SYSTEMS; B TYPE-I; OLEFIN METATHESIS; ALPHA-HELICES; BH3; HELIX; CD81; ENTRY; INFECTION; PROTEINS; RECEPTOR;

D O I：

10.1016/j.bmc.2013.02.011

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The strategy of peptide stapling was used to develop new molecules to inhibit the hepatitis C virus infection via disrupting the binding of HCV envelope glycoprotein E2 with human cell surface protein CD81. The peptide sequence was designed based on the large extra-cellular loop of CD81 with known importance in the HCV E2 binding interaction. Our results showed that the stapled peptides exhibited significantly higher alpha-helicity and proteolytic stability as compared to their linear peptide counterpart. The optimal compound was found to have an EC50 value of ca. 17-39 mu M against different HCV subtypes and represented a new HCV membrane fusion inhibitor. (C) 2013 Elsevier Ltd. All rights reserved.

引用

页码：3547 / 3554

页数：8

共 50 条

[31] In silico design of potential Mcl-1 peptide-based inhibitors
Faraji, Naser
Daly, Norelle L.
Arab, Seyed Shahriar
Khosroushahi, Ahmad Yari
JOURNAL OF MOLECULAR MODELING, 2024, 30 (04)
[32] Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry
Riva, Laura
Song, Ok-ryul
Prentoe, Jannick
Helle, Francois
L'homme, Laurent
Gattolliat, Charles-Henry
Vandeputte, Alexandre
Feneant, Lucie
Belouzard, Sandrine
Baumert, Thomas F.
Asselah, Tarik
Bukh, Jens
Brodin, Priscille
Cocquerel, Laurence
Rouille, Yves
Dubuisson, Jean
JOURNAL OF VIROLOGY, 2018, 92 (10)
[33] Mutagenesis of the fusion peptide-like domain of hepatitis C virus E1 glycoprotein: involvement in cell fusion and virus entry
Li, Hsiao-Fen
Huang, Chia-Hsuan
Ai, Li-Shuang
Chuang, Chin-Kai
Chen, Steve S. L.
JOURNAL OF BIOMEDICAL SCIENCE, 2009, 16
[34] Synthesis and evaluation of hexahydropyrimidines and diamines as novel hepatitis C virus inhibitors
Hwang, Jong Yeon
Kim, Hee-Young
Jo, Suyeon
Park, Eunjung
Choi, Jihyun
Kong, Sunju
Park, Dong-Sik
Heo, Ja Myung
Lee, Jong Seok
Ko, Yoonae
Choi, Inhee
Cechetto, Jonathan
Kim, Jaeseung
Lee, Jinhwa
No, Zaesung
Windisch, Marc Peter
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 70 : 315 - 325
[35] Design of stapled peptide-based PROTACs for MDM2/MDMX atypical degradation and tumor suppression
Chen, Si
Li, Xiang
Li, Yinghua
Yuan, Xing
Geng, Chenchen
Gao, Songyan
Li, Jinyang
Ma, Bohan
Wang, Zhe
Lu, Wuyuan
Hu, Hong-Gang
THERANOSTICS, 2022, 12 (15): : 6665 - 6681
[36] Reduction of hepatitis C virus by dialysis membrane
Kuramochi G.
Shima K.
Journal of Artificial Organs, 2001, 4 (2) : 146 - 149
[37] New potent biaryl sulfate-based hepatitis C virus inhibitors
You, Youngsu
Kim, Hee Sun
Bae, Il Hak
Lee, Seung Gi
Jee, Min Hyeok
Keum, Gyochang
Jang, Sung Key
Kim, B. Moon
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 125 : 87 - 100
[38] Computational Identification of a New Binding Site in Influenza Virus Hemagglutinin for Membrane Fusion Inhibitors
Sun, Lidan
Tian, Feng
Feng, Baosheng
Liu, Zhenming
Zhang, Liangren
Pei, Jianfeng
CHEMICAL BIOLOGY & DRUG DESIGN, 2013, 82 (03) : 267 - 274
[39] The Therapeutic Approaches for Hepatitis C Virus: Protease Inhibitors and Polymerase Inhibitors
Kwo, Paul Y.
Vinayek, Rakesh
GUT AND LIVER, 2011, 5 (04) : 406 - 417
[40] Rational design and screening of peptide-based inhibitors of heat shock factor 1 (HSF1)
Ran, Xu
Burchfiel, Eileen T.
Dong, Bushu
Rettko, Nicholas J.
Dunyak, Bryan M.
Shao, Hao
Thiele, Dennis J.
Gestwicki, Jason E.
BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (19) : 5299 - 5306

← 1 2 3 4 5 →